Santen Pharmaceutical Co., Ltd. (TYO:4536)
1,483.00
-182.00 (-10.93%)
Aug 8, 2025, 3:30 PM JST
Blueprint Medicines Market Cap
Santen Pharmaceutical has a market cap or net worth of 549.99 billion as of August 8, 2025. Its market cap has decreased by -13.76% in one year.
Market Cap
549.99B
Enterprise Value
464.36B
Revenue
300.00B
Ranking
n/a
PE Ratio
16.06
Stock Price
$1,483.00
Market Cap Chart
Since January 14, 1992, Santen Pharmaceutical's market cap has increased from 150.82B to 549.99B, an increase of 264.67%. That is a compound annual growth rate of 3.93%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 7, 2025 | 549.99B | -0.45% |
Dec 30, 2024 | 552.48B | 8.00% |
Dec 29, 2023 | 511.57B | 23.49% |
Dec 30, 2022 | 414.25B | -26.39% |
Dec 30, 2021 | 562.77B | -15.93% |
Dec 30, 2020 | 669.41B | -19.63% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Chugai Pharmaceutical | 12.18T |
Daiichi Sankyo Company | 6,663.39B |
Takeda Pharmaceutical Company | 6,607.23B |
HOYA Corporation | 6,411.30B |
Otsuka Holdings | 4,034.40B |
Terumo | 3,731.89B |
Astellas Pharma | 2,872.55B |
Shionogi & | 2,231.61B |